The store will not work correctly when cookies are disabled.
N-(2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene)methanamine hydrobromide
ID: ALA3913449
Max Phase: Preclinical
Molecular Formula: C15H14BrN3S
Molecular Weight: 267.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Br.C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1
Standard InChI: InChI=1S/C15H13N3S.BrH/c1-16-15-17-14(12-8-4-2-5-9-12)18(19-15)13-10-6-3-7-11-13;/h2-11H,1H3;1H/b16-15+;
Standard InChI Key: YJYGOWVFDGULLL-GEEYTBSJSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
16.2458 -11.3959 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
12.9566 -11.9036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7399 -12.6997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4300 -13.1518 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.0734 -12.6351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7807 -11.8638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2292 -11.1744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0541 -11.2223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5062 -10.5329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1345 -9.7951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3061 -9.7509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8578 -10.4413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8688 -12.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0783 -13.6489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8737 -13.8658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4604 -13.2843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2463 -12.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4513 -12.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9682 -12.9922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3290 -12.4703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 2 2 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
6 7 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
5 13 1 0
3 19 2 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 267.36 | Molecular Weight (Monoisotopic): 267.0830 | AlogP: 3.13 | #Rotatable Bonds: 2 |
Polar Surface Area: 30.18 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.13 | CX LogP: 3.99 | CX LogD: 3.99 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.70 | Np Likeness Score: -0.75 |
References
1. (2014) Dimethylarginine Dimethylaminohydrolase inhibitors and methods of use thereof, |